E
Tactical Resources Corp. RARE.V
TSX
Recommendation
Prev Close
$7.00
Volume
--
Avg Vol (90D)
4,385
Market Cap
$37.31M
Dividend & Yield
--
52-Week Range
$0.95 - $10.25
P/E (TTM)
--
EPS (TTM)
-$0.67
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Howard Horn Sells 3,081 Shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock
12/12/2025 - MarketBeat
Frontier Capital Management Co. LLC Invests $19.11 Million in Ultragenyx Pharmaceutical Inc. $RARE
12/12/2025 - MarketBeat
Insider Sell: Howard Horn Sells Shares of Ultragenyx Pharmaceutical Inc (RARE)
12/11/2025 - GuruFocus
How Attractive Is Ultragenyx Pharmaceutical After Recent Rare Disease Pipeline Progress?
12/11/2025 - Simply Wall St
Ultragenyx Pharmaceutical (NASDAQ:RARE) CFO Howard Horn Sells 3,081 Shares
12/11/2025 - MarketBeat
Is Ultragenyx Pharmaceutical (RARE) One of the Best Biotech Stocks to Buy According to Wall Street Analysts?
12/11/2025 - Yahoo! Finance: News
Is Ultragenyx Pharmaceutical (RARE) One of the Best Biotech Stocks to Buy According to Wall Street Analysts?
12/11/2025 - Insider Monkey
Bank of Nova Scotia Purchases Shares of 241,985 Ultragenyx Pharmaceutical Inc. $RARE
12/11/2025 - MarketBeat
15 Best Biotech Stocks to Buy According to Wall Street Analysts
12/11/2025 - Insider Monkey
Ultragenyx Pharmaceutical (NASDAQ:RARE) Shares Gap Up - What's Next?
12/8/2025 - Zolmax
Ultragenyx Pharmaceutical (NASDAQ:RARE) Shares Gap Up - Time to Buy?
12/8/2025 - MarketBeat
Norges Bank Invests $35.77 Million in Ultragenyx Pharmaceutical Inc. $RARE
12/8/2025 - MarketBeat
Ultragenyx Pharmaceutical Inc. $RARE Holdings Boosted by Hsbc Holdings PLC
12/6/2025 - MarketBeat
Ultragenyx Pharmaceutical (RARE, $36.45) price may drop as it broke higher Bollinger Band on Dec 03, 2025
12/4/2025 - Tickeron - Stocks
Ultragenyx Pharmaceutical Inc at Evercore ISI Healthcare Conference Transcript
12/4/2025 - GuruFocus
Ultragenyx (RARE) Up 14.4% Since Last Earnings Report: Can It Continue?
12/4/2025 - Zacks Investment Research
Ultragenyx Pharmaceutical Inc. $RARE Shares Sold by Sands Capital Management LLC
12/4/2025 - MarketBeat
Ultragenyx Pharmaceutical Inc. (RARE) Presents at Evercore 8th Annual Healthcare Conference Transcript
12/3/2025 - SeekingAlpha
Ultragenyx Pharmaceutical Inc. (RARE) Presents at Evercore 8th Annual Healthcare Conference Transcript
12/3/2025 - Seeking Alpha: Transcripts
Skandinaviska Enskilda Banken AB publ Has $2.46 Million Stock Position in Ultragenyx Pharmaceutical Inc. $RARE
12/3/2025 - MarketBeat
Ultragenyx Pharmaceutical Inc. (RARE) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
12/3/2025 - SeekingAlpha
Ultragenyx Pharmaceutical Inc. (RARE) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
12/3/2025 - Seeking Alpha: Transcripts
Ultragenyx Pharmaceutical Inc at Citi Global Healthcare Conference Transcript
12/3/2025 - GuruFocus
Franklin Resources Inc. Decreases Stake in Ultragenyx Pharmaceutical Inc. $RARE
11/30/2025 - MarketBeat
Ultragenyx Pharmaceutical (RARE): Evaluating Valuation After Analyst Commentary on Setrusumab Progress and Growth Outlook
11/30/2025 - Simply Wall St
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$1.97M
EBIT (TTM)
-$1.97M
Net Income (TTM)
-$4.75M
Balance Sheet
Total Assets (Q)
$315.20K
Total Debt (Q)
$486.10K
Total Liabilities (Q)
$5.53M
Book Value Per Share (Q)
-$0.7304
Cash Flow
Cash from Operations (TTM)
-$324.70K
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$333.80K
Net Change in Cash (TTM)
$9.00K
Filings
Filing Date
Friday, November 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
End of December (est)
Price History
Loading...
Beta
-0.75
7-Day Total Return
-80.00%
30-Day Total Return
-80.42%
60-Day Total Return
-62.67%
90-Day Total Return
-58.21%
Year to Date Total Return
12.00%
1-Year Total Return
5.66%
2-Year Total Return
460.00%
3-Year Total Return
-43.43%
5-Year Total Return
--
52-week Low
Jan 09, 2025 - $0.95
52-week High
Oct 16, 2025 - $10.25
Valuation
Market Cap
$37.31M - Nano Cap
Enterprise Value
$37.76M
Price/Sales (TTM)
--
Price/Book (Q)
-9.58
Dividends and Shares
Shares Outstanding
7.13
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
tacticalresources.com
Phone Number
778-588-5483
Address
1500 Royal Centre
1055 West Georgia Street - PO Box 11117
Vancouver, BC V6E 4N7
Country
Canada
Year Founded
2018
Business Description
Sector
Materials
Industry
Materials
Tactical Resources Corp. acquires, explores, and develops mineral resource properties in Canada. The company primarily explores for rare earth element deposits. Its flagship project is the Peak... more